Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Share-based Compensation (2016 - 2021)

Kraig Biocraft Laboratories (KBLB) has disclosed Share-based Compensation for 10 consecutive years, with $262015.0 as the latest value for Q3 2021.

  • Quarterly Share-based Compensation changed N/A to $262015.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $242100.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $834600.0 for FY2025, N/A changed from the prior year.
  • Share-based Compensation hit $262015.0 in Q3 2021 for Kraig Biocraft Laboratories, up from -$19915.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $842850.0 in Q2 2017 to a low of -$19915.0 in Q2 2019.
  • Historically, Share-based Compensation has averaged $232537.2 across 4 years, with a median of $72575.0 in 2018.
  • Biggest YoY gain for Share-based Compensation was 1306.22% in 2018; the steepest drop was 1306.22% in 2018.
  • Year by year, Share-based Compensation stood at $842850.0 in 2017, then tumbled by 91.39% to $72575.0 in 2018, then tumbled by 127.44% to -$19915.0 in 2019, then skyrocketed by 1415.67% to $262015.0 in 2021.
  • Business Quant data shows Share-based Compensation for KBLB at $262015.0 in Q3 2021, -$19915.0 in Q2 2019, and $72575.0 in Q1 2018.